Addiction Medicine
News from the FDA/CDC
High schoolers prefer tobacco as vapor, not smoke
“The dramatic increase in electronic vapor product use among high school students has led to increases in overall tobacco product use.”
News
CDC data confirm mental health is suffering during COVID-19
The prevalence of symptoms of anxiety disorder alone was roughly three times that reported in the second quarter of 2019.
Conference Coverage
Stress, COVID-19 contribute to mental health concerns in college students
In a spring survey of students published by Active Minds about COVID-19 and its impact on mental health, 91% of students reported having stress or...
News
Lawmakers question mental health disclosure rules
The AMA, AAFP, and others have signed a statement encouraging organizations not to inquire about clinicians and health care staff’s previous...
Conference Coverage
Report describes intoxication with new psychoactive substance
A case report is the first to detail clinical toxicity from flualprazolam, a designer benzodiazepine, and it probably isn’t the last time.
News
Former smokers using e-cigarettes at risk for cigarette smoking relapse
“Determining pharmacologic, behavioral, or some other explanation for these findings may require laboratory-based research,” the authors wrote.
News
Irritability strongly linked to suicidal behavior in major depression
The association between irritability and suicidality was two to 11 times stronger than the link to overall depression, the investigators reported...
News
NIMH strategic plan returns balance to research priorities
The NIMH’s strategic plan renews and expands a focus on suicide prevention, early intervention in psychosis, and the needs of diverse populations...
News
Smokers who are unmotivated to quit smoke more with e-cigarettes
“In our study, people vaping in addition to smoking actually started smoking more,” said study lead investigator Nancy Anoruo, MD.
News
Movement-based yoga ‘viable’ for depression in many mental disorders
Individuals who performed yoga showed a greater reduction in depressive symptoms, compared with the three control groups.